{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:23:59Z","timestamp":1794939839952,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.parkreldis.2024.106102","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T06:01:50Z","timestamp":1710568910000},"page":"106102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The role of peripheral inflammation-related biomarkers in distinguishing Parkinson's disease"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0083-3666","authenticated-orcid":false,"given":"Zhuo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3579-531X","authenticated-orcid":false,"given":"Xin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2024.106102_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2591248","article-title":"Vascular inflammation is a risk factor associated with brain atrophy and disease severity in Parkinson's disease: a case-control study","volume":"2020","author":"Yu","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.parkreldis.2024.106102_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12944-021-01462-4","article-title":"Compared with the monocyte to high-density lipoprotein ratio (MHR) and the neutrophil to lymphocyte ratio (NLR), the neutrophil to high-density lipoprotein ratio (NHR) is more valuable for assessing the inflammatory process in Parkinson's disease","volume":"20","author":"Liu","year":"2021","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.parkreldis.2024.106102_bib3","doi-asserted-by":"crossref","first-page":"e1391","DOI":"10.1212\/WNL.0000000000011553","article-title":"Association of high-density lipoprotein cholesterol variability and the risk of developing Parkinson disease","volume":"96","author":"Park","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2024.106102_bib4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ana.25557","article-title":"Increased immune activation by pathologic \u03b1-synuclein in Parkinson's disease","volume":"86","author":"Grozdanov","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2024.106102_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/mds.28411","article-title":"Genetic and environmental factors in Parkinson's disease converge on immune function and inflammation","volume":"36","author":"Kline","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2024.106102_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116638","article-title":"Differential leukocyte count is associated with clinical phenotype in Parkinson's disease","volume":"409","author":"Umehara","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2024.106102_bib7","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/mds.27815","article-title":"Alterations in blood monocyte functions in Parkinson's disease","volume":"34","author":"Nissen","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2024.106102_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136692","article-title":"Peripheral blood inflammatory cytokines are associated with rapid eye movement sleep behavior disorder in Parkinson's disease","volume":"782","author":"Wang","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2024.106102_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105480","article-title":"Neutrophil-to-lymphocyte ratio and lymphocyte count reflect alterations in central neurodegeneration-associated proteins and clinical severity in Parkinson Disease patients","volume":"112","author":"Grillo","year":"2023","journal-title":"Parkinsonism Relat D"},{"key":"10.1016\/j.parkreldis.2024.106102_bib10","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s10072-021-05507-5","article-title":"Investigation of the peripheral inflammation (neutrophil\u2013lymphocyte ratio) in two neurodegenerative diseases of the central nervous system","volume":"43","author":"Kara","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2024.106102_bib11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3233\/JPD-212914","article-title":"Peripheral immune cell numbers and C-reactive protein in Parkinson's disease: results from a population-based study","volume":"12","author":"Dommershuijsen","year":"2022","journal-title":"JPD"},{"key":"10.1016\/j.parkreldis.2024.106102_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105890","article-title":"Abnormal immune function of B lymphocyte in peripheral blood of Parkinson's disease","volume":"116","author":"Zhang","year":"2023","journal-title":"Parkinsonism Relat D"},{"key":"10.1016\/j.parkreldis.2024.106102_bib13","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/mds.28685","article-title":"Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinson's disease","volume":"36","author":"Mu\u00f1oz-Delgado","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2024.106102_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ana.26034","article-title":"International Parkinson's disease genomics consortium (IPDGC), lower lymphocyte count is associated with increased risk of Parkinson's disease","volume":"89","author":"Jensen","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2024.106102_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2022-330394","article-title":"Prognostic significance of peripheral neutrophils and lymphocytes in early untreated Parkinson's disease: an 8-year follow-up study","author":"Kim","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.parkreldis.2024.106102_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fimmu.2014.00508","article-title":"Neutrophil-derived cytokines: facts beyond expression","volume":"5","author":"Tecchio","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.parkreldis.2024.106102_bib17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.tins.2023.07.005","article-title":"The systemic immune response in Parkinson's disease: focus on the peripheral immune component","volume":"46","author":"Lauritsen","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.parkreldis.2024.106102_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.686066","article-title":"Significant difference of immune cell fractions and their correlations with differential expression genes in Parkinson's disease","volume":"13","author":"Huang","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.parkreldis.2024.106102_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41531-021-00271-x","article-title":"Specific immune status in Parkinson's disease at different ages of onset","volume":"8","author":"Tian","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.parkreldis.2024.106102_bib20","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1073\/pnas.1909110117","article-title":"NK cells clear \u03b1-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of \u03b1-synucleinopathy","volume":"117","author":"Earls","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.parkreldis.2024.106102_bib21","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41583-019-0233-2","article-title":"B cells in autoimmune and neurodegenerative central nervous system diseases","volume":"20","author":"Sabatino","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.parkreldis.2024.106102_bib22","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001125","article-title":"Abnormal B-cell and tfh-cell profiles in patients with Parkinson disease: a cross-sectional study","volume":"9","author":"Li","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.parkreldis.2024.106102_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad060","article-title":"B lymphocyte responses in Parkinson's disease and their possible significance in disease progression","volume":"5","author":"Scott","year":"2023","journal-title":"Brain Commun"},{"key":"10.1016\/j.parkreldis.2024.106102_bib24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3233\/JPD-212535","article-title":"Serum Neurofilament Dynamics Predicts Cognitive Progression in de novo Parkinson's Disease","volume":"11","author":"Ma","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2024.106102_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.parkreldis.2021.02.008","article-title":"Serum NFL levels predict progression of motor impairment and reduction in putamen dopamine transporter binding ratios in de novo Parkinson's disease: an 8-year longitudinal study","volume":"85","author":"Ye","year":"2021","journal-title":"Parkinsonism Relat D"},{"key":"10.1016\/j.parkreldis.2024.106102_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.parkreldis.2021.07.028","article-title":"Serum neurofilament is associated with motor function, cognitive decline and subclinical cardiac damage in advanced Parkinson's disease (MARK-PD)","volume":"90","author":"Niemann","year":"2021","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.parkreldis.2024.106102_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.0b013e31827b1a07","article-title":"Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia","volume":"80","author":"Gomperts","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2024.106102_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.911221","article-title":"Association of plasma and electroencephalography markers with motor subtypes of Parkinson's disease","volume":"14","author":"Yang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.parkreldis.2024.106102_bib29","doi-asserted-by":"crossref","first-page":"64499","DOI":"10.18632\/oncotarget.16469","article-title":"Neutrophil count and percentage: potential independent prognostic indicators for advanced cancer patients in a palliative care setting","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.parkreldis.2024.106102_bib30","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12094-018-1999-9","article-title":"Pretreatment neutrophil\/lymphocyte, platelet\/lymphocyte, lymphocyte\/monocyte, and neutrophil\/monocyte ratios and outcome in elderly breast cancer patients","volume":"21","author":"Losada","year":"2019","journal-title":"Clin. Transl. Oncol."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024001147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024001147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T08:30:55Z","timestamp":1717317055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802024001147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":30,"alternative-id":["S1353802024001147"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106102","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of peripheral inflammation-related biomarkers in distinguishing Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106102"}}